2013 Proves Successful Year for Bioscience in Colorado

Colorado realized a number of key financings and acquisitions in the bioscience industry during 2013. The announcement is made by April Giles, President and CEO of the Colorado BioScience Association (CBSA), who says "We saw several exciting deals this year with many more on the horizon as Colorado continues to gain national recognition in the bioscience industry."

Highlighted Financing and Acquisitions in 2013 Include (deals over $8M):

• Biodesix Closes $8.8M Series D Financing - April 11, 2013 Boulder based Biodesix, Inc., announced that the company closed on $8.8 million in a follow-on sale of its Series D preferred shares. http://www.biodesix.com/biodesix-closes-series-d-financing-2/ 

 • Takeda to Acquire Inviragen for $250M – May 8, 2013 Fort Collins based Inviragen agreed to be acquired by Takeda, the largest pharmaceutical company in Japan for $35 million cash and $215 million in milestones. http://www.takeda.com/news/2013/20130508_5757.htmlhttp://www.takeda.com/news/2013/20130508_5757.html

• Lanx Completes $15M Series C Equity Financing – May 13, 2012 Broomfield based Lanx, Inc., announced the closing of a $15 million Series C equity financing. http://www.lanx.com/pdfs/PR9900-0113_Series%20C%20Equity%20Financing%20Release.pdf 

• Clovis Oncology Raises an Additional $275M – June 18, 2013 Boulder based Clovis Oncology’s initial IPO in 2011 was $139 million on the sale of 10.7 million shares. They raised an additional $75 million in 2012 and $275 million in June of 2013 through public offerings. http://www.xconomy.com/boulder-denver/2013/06/18/clovis-oncology-closes-275m-offering-following-two-pivotal-weeks/ 

• SomaLogic Inc. Raised $10M in Equity Financing – August 20, 2013 Boulder based SomaLogic Inc. raised $10 million in equity financing from unidentified investors. http://www.bizjournals.com/denver/blog/boosters_bits/2013/08/somalogic-raises-venture-capital.html

• Baxter Completes Acquisition of Gambro AB for $4B – September 6, 2013 Lakewood based Gambro BCT, a wholly owned entity of Gambro AB was acquired by Baxter International Inc. of Deerfield, Ill for $4 billion. http://www.baxter.com/press_room/press_releases/2013/09_06_13_gambro.html 

• Ampio Pharmaceuticals, Inc. Announces $25M Financing – September 26, 2013 Greenwood Village based Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced a financing transaction that will provide $25 million in gross proceeds to the company. http://ampiopharma.com/news/ampio-pharmaceuticals-inc-announces-25-million-financing/ 

• Surefire Medical Closes Series B Funding at $18.2M - November 7, 2013 Westminster based Surefire Medical, Inc. completed a $18.2 million Series B funding. The latest financing will be used to expand product development, clinical trials, operations and marketing to meet rapidly growing national and international customer demand. http://surefiremedical.com/news/surefire-medical-closes-series-b-funding-at-18-2-million/

Link to the Business Wire release